Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

FLT PET Imaging for Cervical Cancer
`F-18 Fluorothymidine ([18F]FLT) PET Imaging for Early Evaluation of Response to Chemoradiation Therapy in Patients With Cervical Cancer
Status: Enrolling
Updated:  10/25/2017
Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
FLT PET Imaging for Cervical Cancer
`F-18 Fluorothymidine ([18F]FLT) PET Imaging for Early Evaluation of Response to Chemoradiation Therapy in Patients With Cervical Cancer
Status: Enrolling
Updated: 10/25/2017
Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
A Randomized Phase II Study of Peripheral Androgen Blockade With Bicalutamide Followed by Placebo or Treatment With the Gamma Secretase Inhibitor RO4929097 in Men With Rising PSA After Definitive Local Therapy for Adenocarcinoma of the Prostate
Status: Enrolling
Updated:  10/25/2017
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
A Randomized Phase II Study of Peripheral Androgen Blockade With Bicalutamide Followed by Placebo or Treatment With the Gamma Secretase Inhibitor RO4929097 in Men With Rising PSA After Definitive Local Therapy for Adenocarcinoma of the Prostate
Status: Enrolling
Updated: 10/25/2017
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Miller Children's Hospital
mi
from
Long Beach, CA
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Connecticut Children's Medical Center
mi
from
Hartford, CT
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
A. I. duPont Hospital for Children
mi
from
Wilmington, DE
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
A. I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Children's Hospital of Southwest Florida at Lee Memorial
mi
from
Fort Myers, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Children's Hospital of Southwest Florida at Lee Memorial
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Nemours Children's Clinic - Orlando
mi
from
Orlando, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Nemours Children's Clinic - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
All Children's Hospital
mi
from
Saint Petersburg, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Tampa General Hospital
mi
from
Tampa, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Kapiolani Medical for Women and Children
mi
from
Honolulu, HI
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Kapiolani Medical for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Ochsner Clinic Foundation New Orleans
mi
from
New Orleans, LA
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Ochsner Clinic Foundation New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Dana-Farber Cancer Institute/Boston Children's Hospital
mi
from
Boston, MA
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Dana-Farber Cancer Institute/Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Mercy Children's Hospital
mi
from
Toledo, OH
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Mercy Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Randall Children's Hospital at Legacy Emanuel
mi
from
Portland, OR
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Randall Children's Hospital at Legacy Emanuel
mi
from
Portland, OR
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Methodist Healthcare System of San Antonio
mi
from
San Antonio, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Methodist Healthcare System of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Scott & White Pediatrics
mi
from
Temple, TX
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Scott & White Pediatrics
mi
from
Temple, TX
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Hospital for Sick Children
mi
from
Toronto,
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Children's National Medical Center
mi
from
Washington, D.C.,
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Children's National Medical Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Palms West Hospital
mi
from
Loxahatchee Groves, FL
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Palms West Hospital
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  10/25/2017
Columbia University Medical Center
mi
from
New York, NY
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 10/25/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Stanford Univ Med Ctr
mi
from
Stanford, CA
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Heartland NCORP
mi
from
Decatur, IL
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Heartland NCORP
mi
from
Decatur, IL
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Wichita NCORP
mi
from
Wichita, KA
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Wichita NCORP
mi
from
Wichita, KA
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
University of Rochester
mi
from
Rochester, NY
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated:  10/25/2017
Southeast Clinical Oncology Research Program
mi
from
Winston-Salem, NC
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Feasibility, Acceptability and Mechanisms of Brief Behavioral Therapy (BBT) for Sleep Problems During Chemotherapy: A Phase II Randomized Controlled Trial
Status: Enrolling
Updated: 10/25/2017
Southeast Clinical Oncology Research Program
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Phase I Assessment of NO Mediated Signaling in Cancer Cachexia
Status: Enrolling
Updated:  10/25/2017
University of Texas Medical Branch
mi
from
Galveston, TX
Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Phase I Assessment of NO Mediated Signaling in Cancer Cachexia
Status: Enrolling
Updated: 10/25/2017
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Phase I Study of Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Status: Enrolling
Updated:  10/25/2017
Univ of Hawaii
mi
from
Honolulu, HI
Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Phase I Study of Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Status: Enrolling
Updated: 10/25/2017
Univ of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
11C-acetate for Treatment Response After Radiotherapy for HCC
Feasibility of 11C-acetate in the Monitoring of Treatment Response Following Radiotherapy in Patients With Hepatocellular Carcinoma
Status: Enrolling
Updated:  10/25/2017
Indiana University
mi
from
Indianapolis, IN
11C-acetate for Treatment Response After Radiotherapy for HCC
Feasibility of 11C-acetate in the Monitoring of Treatment Response Following Radiotherapy in Patients With Hepatocellular Carcinoma
Status: Enrolling
Updated: 10/25/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
A Phase II Evaluation of Bortezomib (Velcade™, PS-341, NSC #681239, IND #58443) in the Treatment of Persistent or Recurrent Platinum-Sensitive Epithelial Ovarian or Primary Peritoneal Cancer
Status: Enrolling
Updated:  10/25/2017
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
A Phase II Evaluation of Bortezomib (Velcade™, PS-341, NSC #681239, IND #58443) in the Treatment of Persistent or Recurrent Platinum-Sensitive Epithelial Ovarian or Primary Peritoneal Cancer
Status: Enrolling
Updated: 10/25/2017
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Status: Enrolling
Updated:  10/26/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Status: Enrolling
Updated: 10/26/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients "CapTere"
Status: Enrolling
Updated:  10/26/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients "CapTere"
Status: Enrolling
Updated: 10/26/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients "CapTere"
Status: Enrolling
Updated:  10/26/2017
Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center
mi
from
Miami Beach, FL
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients "CapTere"
Status: Enrolling
Updated: 10/26/2017
Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients "CapTere"
Status: Enrolling
Updated:  10/26/2017
University of Miami
mi
from
Miami, FL
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients "CapTere"
Status: Enrolling
Updated: 10/26/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/26/2017
UTHealth Memorial Hermann Cancer Center
mi
from
Houston, TX
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/26/2017
UTHealth Memorial Hermann Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Docetaxel Followed by Provenge in Metastatic Prostate Cancer
Docetaxel Followed by Provenge in Castration-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/26/2017
UTHealth Memorial Hermann Cancer Center
mi
from
Houston, TX
Docetaxel Followed by Provenge in Metastatic Prostate Cancer
Docetaxel Followed by Provenge in Castration-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/26/2017
UTHealth Memorial Hermann Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
A Phase II Study of GW572016 and Tamoxifen in Patients With Metastatic Breast Cancer Resistant to Single-Agent Tamoxifen
Status: Enrolling
Updated:  10/27/2017
Harper University Hospital - DMC
mi
from
Detroit, MI
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
A Phase II Study of GW572016 and Tamoxifen in Patients With Metastatic Breast Cancer Resistant to Single-Agent Tamoxifen
Status: Enrolling
Updated: 10/27/2017
Harper University Hospital - DMC
mi
from
Detroit, MI
Click here to add this to my saved trials
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
A Phase II Study of GW572016 and Tamoxifen in Patients With Metastatic Breast Cancer Resistant to Single-Agent Tamoxifen
Status: Enrolling
Updated:  10/27/2017
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
A Phase II Study of GW572016 and Tamoxifen in Patients With Metastatic Breast Cancer Resistant to Single-Agent Tamoxifen
Status: Enrolling
Updated: 10/27/2017
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Comparison of FLT and FDG PET in the Evaluation of Response to Cetuximab, Cisplatin and Radiation Therapy in Advanced Head and Neck Malignancies or Response to Standard Chemo-radiotherapy in Esophageal Malignancies
Status: Enrolling
Updated:  10/27/2017
The Mayo Clinic
mi
from
Rochester, MN
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Comparison of FLT and FDG PET in the Evaluation of Response to Cetuximab, Cisplatin and Radiation Therapy in Advanced Head and Neck Malignancies or Response to Standard Chemo-radiotherapy in Esophageal Malignancies
Status: Enrolling
Updated: 10/27/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase II Trial of Novasoy®, Gemcitabine, and Erlotinib in Locally Advanced or Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  10/27/2017
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase II Trial of Novasoy®, Gemcitabine, and Erlotinib in Locally Advanced or Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 10/27/2017
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase II Trial of Novasoy®, Gemcitabine, and Erlotinib in Locally Advanced or Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  10/27/2017
M. D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase II Trial of Novasoy®, Gemcitabine, and Erlotinib in Locally Advanced or Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 10/27/2017
M. D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
A Phase II Evaluation of CCI-779 (Temsirolimus, NCI-Supplied Agent, NSC #683864, IND #61010) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
Status: Enrolling
Updated:  10/27/2017
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
A Phase II Evaluation of CCI-779 (Temsirolimus, NCI-Supplied Agent, NSC #683864, IND #61010) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
Status: Enrolling
Updated: 10/27/2017
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Bethesda, MD
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials